Hospital
East Carolina Health
East Carolina Health was paid $8.26M by Medicaid between Jan 2018 and Dec 2024, across 114 billing codes. Its largest line is 99283, emergency room visit (moderate) — 30% of everything it billed.
33Billing provider infoEAST CAROLINA HEALTH
AHOSKIE, NC 27910
AHOSKIE, NC 27910
33aNPI1467441394assigned 10/13/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$8.26M
24GClaims165,878
24DCodes billed114
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in North Carolina
Rank by total paid#57 of 92
Median peer was paid$11.47M
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 27,241 | $926K | |
| 2019 | 17,295 | $723K | |
| 2020 | 14,281 | $498K | |
| 2021 | 20,761 | $1.07M | |
| 2022 | 24,116 | $1.52M | |
| 2023 | 26,844 | $1.62M | |
| 2024incomplete | 35,340 | $1.90M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 30% | 21,746 | 20,514 | $2.51M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 28% | 11,717 | 11,064 | $2.29M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.1% | 4,527 | 4,286 | $752K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 4.1% | 2,081 | 2,004 | $342K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.9% | 2,567 | 2,476 | $239K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 2.4% | 20,656 | 17,110 | $201K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.4% | 5,464 | 5,177 | $195K |
| 71045 | Radiologic examination, chest; single view | 2.3% | 3,804 | 3,608 | $190K |
| 62323 | 1.9% | 846 | 784 | $160K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.5% | 18,696 | 16,756 | $127K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.5% | 3,392 | 3,172 | $122K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.3% | 1,365 | 1,265 | $111K |
102 more codes
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.2% | 2,635 | $95K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.1% | 2,637 | $95K |
| 80053 | Comprehensive metabolic panel | <1% | 10,719 | $80K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,166 | $68K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 2,363 | $64K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 1,683 | $54K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 804 | $39K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,088 | $36K |
| 81001 | <1% | 9,526 | $30K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 745 | $30K |
| 36591 | <1% | 2,702 | $29K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 167 | $28K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,618 | $25K |
| 0225U | <1% | 58 | $23K | |
| 86780 | <1% | 992 | $21K | |
| 84484 | <1% | 2,414 | $20K | |
| 81025 | <1% | 2,176 | $19K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 853 | $19K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 487 | $19K |
| 87088 | <1% | 1,650 | $17K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 199 | $13K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 501 | $12K |
| 11056 | <1% | 1,022 | $10K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 185 | $10K |
| 83735 | <1% | 1,755 | $10K | |
| 83690 | <1% | 1,204 | $8K | |
| J3490 | Unclassified drugs | <1% | 1,090 | $8K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 985 | $7K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 115 | $7K |
| 86762 | <1% | 371 | $7K | |
| 86850 | <1% | 440 | $6K | |
| 82728 | <1% | 524 | $6K | |
| 86003 | <1% | 57 | $5K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,700 | $5K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 14 | $5K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 458 | $5K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 13 | $5K |
| 84466 | <1% | 444 | $5K | |
| 87340 | <1% | 393 | $4K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 162 | $4K |
| 86803 | <1% | 204 | $4K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 13 | $4K |
| 86787 | <1% | 231 | $4K | |
| 0352U | <1% | 110 | $4K | |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | <1% | 16 | $4K |
| 83880 | <1% | 174 | $3K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 695 | $3K |
| 86592 | <1% | 690 | $3K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 144 | $3K |
| 83540 | <1% | 442 | $3K | |
| 87430 | <1% | 176 | $2K | |
| 11721 | <1% | 439 | $2K | |
| 86900 | <1% | 441 | $2K | |
| 86901 | <1% | 441 | $2K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 38 | $2K |
| 82962 | <1% | 692 | $2K | |
| 73630 | <1% | 15 | $956.61 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 150 | $945.89 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 43 | $878.98 |
| 81003 | <1% | 340 | $815.51 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 58 | $797.23 |
| 20610 | <1% | 12 | $760.54 | |
| 87081 | <1% | 111 | $736.21 | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 38 | $721.46 |
| 11720 | <1% | 161 | $680.68 | |
| 82950 | <1% | 110 | $655.73 | |
| 77002 | <1% | 12 | $622.08 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 28 | $587.98 |
| 86703 | <1% | 313 | $544.00 | |
| 87210 | <1% | 79 | $497.09 | |
| 94060 | <1% | 28 | $491.95 | |
| 94729 | <1% | 29 | $489.03 | |
| 94726 | <1% | 28 | $489.03 | |
| A4217 | Sterile water/saline, 500 ml | <1% | 73 | $412.12 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 147 | $396.41 |
| 82785 | <1% | 54 | $386.70 | |
| J2704 | Injection, propofol, 10 mg | <1% | 59 | $379.54 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 12 | $378.00 |
| 84480 | <1% | 15 | $368.42 | |
| 84436 | <1% | 42 | $348.27 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 137 | $344.24 |
| 85027 | <1% | 65 | $310.15 | |
| 84702 | <1% | 26 | $261.60 | |
| 87070 | <1% | 26 | $257.52 | |
| 83970 | <1% | 16 | $245.99 | |
| 85018 | <1% | 79 | $241.24 | |
| 85014 | <1% | 78 | $238.29 | |
| 80061 | Lipid panel | <1% | 14 | $233.80 |
| 94664 | <1% | 29 | $230.40 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 40 | $227.16 |
| 83605 | <1% | 37 | $224.75 | |
| 83525 | <1% | 13 | $185.25 | |
| 87807 | <1% | 14 | $128.52 | |
| 36000 | <1% | 12 | $112.91 | |
| 84479 | <1% | 12 | $89.16 | |
| 82947 | <1% | 13 | $63.57 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | <1% | 93 | $61.69 |
| 80069 | <1% | 12 | $39.52 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 13 | $35.78 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 12 | $30.24 |
| G1010 | Clinical decision support mechanism stanson, as defined by the medicare appropriate use criteria program | <1% | 232 | $17.23 |
| 94375 | 0% | 26 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHARVILL, BRIAN (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| East Carolina Health-Bertie | Windsor, NC | $654K |
| East Carolina Health | Ahoskie, NC | $58K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.